Identity
- Security key
- 18747
- Ticker
- MRK
- Type
- CS — Common Stock
- Exchange
- New York Stock Exchange(XNYS)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1949-04-20
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- MRK
Detail
Enriched 2026-08-14 20:47
- Market cap
- $327,936,454,122.96
- Shares outstanding (class)
- 2,469,824,415
- Shares outstanding (weighted)
- 2,467,171,638
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 75,000
- Location
- RAHWAY, NJ
- Homepage
- https://www.merck.com
- Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).